• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.16% Nasdaq Up 0.03%

    More On IMU.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Imugene Ltd. (IMU.AX)

    -ASX
    0.01 0.00(0.00%) Dec 17, 6:30PM EST
    Add to Portfolio
    Prev Close:0.01
    Open:0.01
    Bid:0.01
    Ask:0.01
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.01 - 0.01
    52wk Range:0.01 - 0.02
    Volume:350,000
    Avg Vol (3m):747,884
    Market Cap:9.47M
    P/E (ttm):N/A
    EPS (ttm):-0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.12
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Imugene Limited, an immuno-oncology biopharmaceutical company, together with its subsidiaries, engages in the research and development of novel antisense pharmaceuticals in Australia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback